From Proteopedia
(Difference between revisions)
proteopedia linkproteopedia link
|
|
Line 1: |
Line 1: |
- | [[Image:1oxq.jpg|left|200px]] | + | {{Seed}} |
| + | [[Image:1oxq.png|left|200px]] |
| | | |
| <!-- | | <!-- |
Line 9: |
Line 10: |
| {{STRUCTURE_1oxq| PDB=1oxq | SCENE= }} | | {{STRUCTURE_1oxq| PDB=1oxq | SCENE= }} |
| | | |
- | '''Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (ML-IAP)'''
| + | ===Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (ML-IAP)=== |
| | | |
| | | |
- | ==Overview==
| + | <!-- |
- | Melanoma inhibitor of apoptosis (ML-IAP) is a potent anti-apoptotic protein that is upregulated in a number of melanoma cell lines but not expressed in most normal adult tissues. Overexpression of IAP proteins, such as ML-IAP or the ubiquitously expressed X-chromosome-linked IAP (XIAP), in human cancers has been shown to suppress apoptosis induced by a variety of stimuli. Peptides based on the processed N-terminus of Smac/DIABLO can negate the ability of overexpressed ML-IAP or XIAP to suppress drug-induced apoptosis. Such peptides have been demonstrated to bind to the single baculovirus IAP repeat (BIR) of ML-IAP and the third BIR of XIAP with similar high affinities (approximately 0.5 microM). Herein, we use phage-display of naive peptide libraries and synthetic peptides to investigate the peptide-binding properties of ML-IAP-BIR and XIAP-BIR3. X-ray crystal structures of ML-IAP-BIR in complex with Smac- and phage-derived peptides, together with peptide structure-activity-relationship data, indicate that the peptides can be modified to provide increased binding affinity and selectivity for ML-IAP-BIR relative to XIAP-BIR3. For instance, substitution of Pro3' in the Smac-based peptide (AVPIAQKSE) with (2S,3S)-3-methylpyrrolidine-2-carboxylic acid [(3S)-methyl-proline] results in a peptide with 7-fold greater affinity for ML-IAP-BIR and about 100-fold specificity for ML-IAP-BIR relative to XIAP-BIR3.
| + | The line below this paragraph, {{ABSTRACT_PUBMED_12846571}}, adds the Publication Abstract to the page |
| + | (as it appears on PubMed at http://www.pubmed.gov), where 12846571 is the PubMed ID number. |
| + | --> |
| + | {{ABSTRACT_PUBMED_12846571}} |
| | | |
| ==About this Structure== | | ==About this Structure== |
Line 35: |
Line 39: |
| [[Category: Peptide complex]] | | [[Category: Peptide complex]] |
| [[Category: Zinc binding]] | | [[Category: Zinc binding]] |
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 04:24:27 2008'' | + | |
| + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 22:59:18 2008'' |
Revision as of 19:59, 27 July 2008
Template:STRUCTURE 1oxq
Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (ML-IAP)
Template:ABSTRACT PUBMED 12846571
About this Structure
1OXQ is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP)., Franklin MC, Kadkhodayan S, Ackerly H, Alexandru D, Distefano MD, Elliott LO, Flygare JA, Mausisa G, Okawa DC, Ong D, Vucic D, Deshayes K, Fairbrother WJ, Biochemistry. 2003 Jul 15;42(27):8223-31. PMID:12846571
Page seeded by OCA on Sun Jul 27 22:59:18 2008
Categories: Homo sapiens | Single protein | Ackerly, H. | Alexandru, D. | Deshayes, K. | Distefano, M D. | Elliott, L O. | Fairbrother, W J. | Flygare, J A. | Franklin, M C. | Kadkhodayan, S. | Vucic, D. | Apoptosis inhibition | Peptide complex | Zinc binding